Nourishing GLP-1 Therapy for Obesity
This academic article, “Nutritional priorities to support GLP‐1 therapy for obesity,” is a joint advisory from several prominent American health organizations. It examines the use of GLP-1 receptor agonists (GLP-1s) for obesity treatment, highlighting their efficacy in weight reduction and other clinical benefits while also addressing significant challenges like gastrointestinal side effects, potential nutrient deficiencies, and loss of muscle and bone mass. The authors […]
GLP-1 Less Frequent Dosing May Maintain Weight Loss
A study of real-world and virtual patients suggests that a less frequent dosing of glucagon-like peptide 1 receptor agonists is an effective and cost-saving strategy for long-term weight maintenance. Medscape Medical News
US administration will set targets to slash drug prices
What’s happened? On May 12th US president Donald Trump issued an executive order (EO) announcing plans to drastically lower prescription drug prices in the country. The order kickstarts negotiations that aim to force pharmaceutical companies to cut their US prices to match those charged in other developed countries, on a “most-favoured nation” basis. While the […]
8 Ways to Boost the Effects of Ozempic and Other GLP-1 Drug Treatments
According to leaders in obesity and nutrition research, following these key nutrition guidelines will make the most of GLP-1 drug treatment.